Annals of Hepato-Biliary-Pancreatic Surgery

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2508-5859   pISSN 2508-5778

Table. 3.

Table. 3.

iagnosis and treatment

Immunohistochemistry Treatment
Mesenchymal cell (VIMENTIN) (+) Watching and waiting
Marker for stromal cell CD117(−) CD34(−) Radical resection: recurrence 19-77%
Neural cell S-100(−) Non-steroidal anti-inflammatory drugs (NSAIDs)
Beta-catenin (+) Hormonaltherapy non-steroidal benzothiophene (tamoxifen or raloxifen) Interferon Chemotherapy(vinbrastine, methotrexate, doxorubicin and dacarbazine) Imatinib
Ann Hepatobiliary Pancreat Surg 2021;25:276-82 https://doi.org/10.14701/ahbps.2021.25.2.276
© 2021 Ann Hepatobiliary Pancreat Surg